Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
Riedl-Seifert
R J
RJ
Clinical Research Department, Luitpold Pharma GmbH, Munich, Germany.
van Aubel
A
A
Kämmereit
A
A
Elsasser
U
U
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000284:Administration, Oral; D001424:Bacterial Infections / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy*; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D018928:Immunity, Mucosal; D008297:Male; D012008:Recurrence; D012141:Respiratory Tract Infections / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy*; D014611:Vaccination / Q000009:adverse effects / Q000379:methods*
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; C078795:LW 50020